Our study has linked cholesterol metabolism genes (MVK, HMGCS1, TM7SF2, and FDPS) to NAFLD, providing a promising diagnostic framework, identifying treatment targets, and offering novel perspectives into its mechanisms. This evidence concerns the gene FDPS and metabolic dysfunction-associated steatotic liver disease.